The Growth Hormone (GH)/ Prolactin (PRL) Family in Biology & Disease Conference

May 15–19, 2022

Athens, OH

Summary

May 15-19, 2022

The aim of this FASEB Science Research Conference (SRC) is to improve our understanding of the regulation and action of growth hormone (GH) and prolactin (PRL) and their specific receptors.

It is well established that GH and PRL regulate growth and lactation, respectively. It is now clear, however, that "GH/PRL hormones" define a family of hormones acting through cytokine receptors, with actions that extend far beyond their originally identified physiological functions—these include regulation of metabolism, inflammation, angiogenesis, fetal programming, cell (stem) recruitment/ proliferation, behavior, and neurogenesis—with implications for the etiology and treatment of diseases such as type-2 diabetes, obesity, arthritis, osteoporosis, psychiatric disorders and cancer.

This SRC evolved from a long-standing prolactin conference that expanded in scope to cover the wide range of functions of the growth hormone/prolactin family of hormones. It has been running under the FASEB banner since 2012 with a worthy goal: that the mixture of fundamental basic science through to clinical research into these pleiotropic hormones will accelerate the translation of knowledge into novel clinical applications.

The conference will present and integrate novel research advances in GH/PRL biology to raise the profile of the field and foster new national and international collaborative projects. A key aspect is to encourage and support emerging investigators/trainees and the participation of under-represented groups.

Program

The main themes of the conference are: 1) The control of secretion of the GH and prolactin family of hormones, and the actions of these pleiotrophic hormones throughout the body; 2) How the function of these hormones change in various disease states; 3) Therapeutic opportunities of manipulating hormone action.

Conference sessions will present the latest research and foster discussion on:
  • Dynamics of hormone gene expression and secretion
  • Heterogeneity of cell types secreting and responding to GH/PRL
  • Neuroendocrinology and behavior
  • Placental lactogens and somatotropins
  • Novel clinical insights
  • Novel drugs and therapeutic opportunities using the GH/PRL family
  • Pleiotropic functions of prolactin and growth hormone
  • Aging and cancer

The conference covers ten sessions with 20 talks based on abstract submissions. For trainees and emerging researchers, the conference features a "Meet the Experts" session with leaders in the field and two interactive, discussion-focused Career Development Sessions with established researchers. All questions are welcome!

Keynote Lecture

John Kopchick, PhD, Ohio University
Vincent Goffin, PhD, INSERM, Paris

Organizers

Grattan_Dav

Dave Grattan, PhD

Professor, University of Otago

Berryman_Darlene

Darlene Berryman, PhD

Associate Dean and Professor, Ohio University

Email Sign Up